M Lynn Crismon
Biographic Data
| ID | 5416032 |
|---|---|
| NAME | M Lynn Crismon |
| GIVEN NAMES | M Lynn |
| FAMILY NAME | Crismon |
| SIGNATURE | CRISMON M L |
| AFFILIATIONS | Austin College |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system
In inpatients with TRS taking adjunct DRBAs (including anticholinergic DRBAs) XT use was commonly discontinued due to intolerability/ineffectiveness. Larger controlled trials are needed to further investigate XT's effectiveness for treating TRS and determine how adjunct anticholinergic use impacts its safety/efficacy
Physician Specialty Associated With Antipsychotic Prescribing for Youths in the Texas Medicaid Program
BACKGROUND/OBJECTIVE: The use of antipsychotics in children and adolescents in the Texas Medicaid program has increased with the introduction of newer atypical antipsychotics. The purpose of this study was to examine physician specialty associated with antipsychotic prescribing from 1996 to 2001. METHODS: All antipsychotic prescription claims records for children and adolescents younger than the age of 20 years from 1996 to 2001 were extracted fr…
A Psychoeducational Program for Children with ADHD or Depression and their Families
No prominent works on this page.
A Psychoeducational Program for Children with ADHD or Depression and their Families
Physician Specialty Associated With Antipsychotic Prescribing for Youths in the Texas Medicaid Program
BACKGROUND/OBJECTIVE: The use of antipsychotics in children and adolescents in the Texas Medicaid program has increased with the introduction of newer atypical antipsychotics. The purpose of this study was to examine physician specialty associated with antipsychotic prescribing from 1996 to 2001. METHODS: All antipsychotic prescription claims records for children and adolescents younger than the age of 20 years from 1996 to 2001 were extracted fr…
Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system
In inpatients with TRS taking adjunct DRBAs (including anticholinergic DRBAs) XT use was commonly discontinued due to intolerability/ineffectiveness. Larger controlled trials are needed to further investigate XT's effectiveness for treating TRS and determine how adjunct anticholinergic use impacts its safety/efficacy
Child and Adolescent Psychosocial and Emotional Development (2 works) · Medicine (2 works) · Nursing (2 works) · Psychiatry (2 works) · Schizophrenia research and treatment (2 works) · Adjunct (1 work) · Anticholinergic (1 work) · Anticholinergic agents (1 work) · Antipsychotic (1 work) · Attention Deficit Hyperactivity Disorder (1 work)